Gardasil
EMA committee recommends five drugs for approval
March 30, 2015Sales and Marketing Boehringer, CHMP, EMA, Eisai, Europe, Gardasil, Lenvima, Merck, akynzio, jardiance, lilly
Cancer and diabetes treatments are among those given the go ahead in the latest round of approvals by the EMA. …
MHRA: Cervarix ‘in clear’
October 1, 2013Sales and Marketing GSK, Gardasil, MHRA, ceravix
Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …
AstraZeneca’s Fluenz chosen for wider flu immunisation
July 26, 2012Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune
The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …
UK government drops Cervarix for Gardasil
November 28, 2011Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi
The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …
Core products boost Merck’s results
October 31, 2011Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis
Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment. Worldwide sales …
Gardasil better value for money than Cervarix, finds new study
September 28, 2011Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer
A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …
Gardasil and Cervarix share innovation prize
September 25, 2008Sales and Marketing Cancer, Gardasil, prix galien, vaccines
Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …
Gardasil approved in Europe
September 22, 2006Sales and Marketing Gardasil
Sanofi Pasteur MSD's Gardasil has been approved as the first ever vaccine to prevent women developing cervical cancer, which remains …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
